Work

TRANSCEND NHL 001: Health-related quality of life (HRQL) and symptom (Sx) impact in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) receiving lisocabtagene maraleucel (Liso-cel; JCAR017).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e19052

Authors: Donald L. Patrick, Karen C. Chung, Yeonhee Kim, Jacob Garcia, Christine Dehner, David G. Maloney

Institutions: University of Washington, Juno Therapeutics (United States), Fred Hutch Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2958966890

Cites:

Cited by: 6

Related to: 10